“I had my third dose of vaccine against Covid-19 on December 2, 2021. I had Covid-19 on May 18, 2022. When can I receive my fourth dose of vaccine, I am 74 years old ? »asks Alice, a reader from Hendaye (Pyrénées-Atlantiques).
You are among those eligible for a fourth dose of vaccine against Covid-19. The second booster is recommended for people aged 60 to 79, pregnant women, adults at risk of severe form and those around them, as indicated in theopinion of the High Authority for Health of July 13, 2022.
The second reminder is also open to all health professionals, employees in the health and medico-social sector, home helpers working with vulnerable people, medical transport professionals and firefighters.
What to do if you have been infected?
In your case Alice, you were infected after the first booster shot. The Vaccine Strategy Guidance Council (COSV), chaired by Alain Fischer, spoke about this scenario.
“Following the opinions of the Vaccine Strategy Guidance Council (COSV) of March 31, 2022 and July 25, 2022, the second vaccination booster against Covid-19 is also recommended from 6 months after the first booster, respecting a period of 3 months after the infection, in the event of an infection occurring after the first reminder”we read on the Ministry of Health website.
“People aged 12 and over eligible for 2e recall and having had Covid-19 between their last injection (1er reminder) and the scheduled date of 2e reminder can receive a 2e booster, in order to increase their protection, from 3 months after infection”specifies the infographic dedicated to the recall campaign.
You can therefore receive a second reminder now because it has been more than three months since you were infected.
New vaccines in October
New vaccines are expected in France in October. The High Authority for Health (HAS) will give its opinion on these bivalent vaccines in mid-September.
The European Medicines Agency (EMA) approved on Thursday 1er September, the new messenger RNA vaccines developed by Moderna and Pfizer BioNTech : their versions developed to target the original strain and the Omicron BA.1 variant are now authorized in Europe.
“These vaccines, which are an evolution of those used since December 2020 to fight the Covid-19 epidemic and which will be available in France in October, will certainly have a place in the vaccine strategy”noted the HAS, on September 5.